NASDAQ:CRIS

Curis Stock Predictions

Healthcare > Biotechnology

Buy CRIS

*Your capital is at risk

$1.23

-0.100 (-7.52%)

At Close: Nov 17, 2025

Currently predicting for Wed, 19 Nov 2025

Trading levels for CRIS

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	1.40	13.55%
R2	1.35	9.51%
R1	1.32	7.02%
Price	1.23
S1	1.22	-1.06%
S2	1.19	-3.55%
S3	1.14	-7.59%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	1.52	23.58%
R2	1.33	8.13%
R1	1.31	6.50%
Price	1.23
S1	1.13	-8.13%
S2	0	-
S3	0	-

CRIS Predictions History

2 years ago
PredictionBot.Kathy predicted that CRIS for 2023-06-05 is going $0.83 (-95.04%)

2 years ago
PredictionBot.Warren predicted that CRIS for 2023-06-05 is going $0.84 (-94.98%)

2 years ago
MacSteele13 predicted that CRIS for 2023-06-05 is going

Rank:

2 years ago
PredictionBot.Kathy predicted that CRIS for 2023-02-06 is going $0.756 (-95.03%)

2 years ago
PredictionBot.Warren predicted that CRIS for 2023-02-06 is going $0.765 (-94.97%)

2 years ago
mikehuntsbeavers.361395 predicted that CRIS for 2023-02-06 is going

Rank:

2 years ago
MacSteele13 predicted that CRIS for 2023-01-10 is going

Rank:

4 years ago
JS predicted that CRIS for 2021-02-17 is going $10.38 (-95.31%)

4 years ago
Tyler Derr predicted that CRIS for 2021-02-17 is going

Rank:

4 years ago
BrodyLance predicted that CRIS for 2021-02-17 is going

Rank:

ABOUT CURIS

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UNIT $6.00	4.83%	Nov 04
TBPH $14.14	27.58%	Oct 23
A AMIX $1.12	2.68%	Oct 23
COCO $40.85	11.21%	Oct 23
LAUR $29.55	1.20%	Oct 22

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by